A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Bladder Cancer Patients.

PURPOSE: Poor prognosis of patients with muscle-invasive bladder cancer (BC) that often metastasizes drives the need for discovery of molecular determinants of BC progression. Chondroitin sulfate proteoglycans, including CD44, regulate cancer progression; however, the identity of a chondroitinase (C...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Cancer Res
Autores principales: Lokeshwar, Vinata B., Morera, Daley S., Hasanali, Sarrah L., Yates, Travis J., Hupe, Marie C., Knapp, Judith S., Lokeshwar, Soum D., Wang, Jiaojiao, Hennig, Martin, Baskar, Rohitha, Escudero, Diogo O., Racine, Ronny R., Dhir, Neetika, Jordan, Andre R., Hoye, Kelly, Azih, Ijeoma, Manoharan, Murugesan, Klaassen, Zachary, Kavuri, Sravankumar, Lopez, Luis E., Ghosh, Santu, Lokeshwar, Bal L.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7334064/
https://ncbi.nlm.nih.gov/pubmed/32094233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-2912
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares